---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-307328"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:18:58.405421+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Nurix amends bylaws to comply with new universal proxy rules and DGCL updates

## Summary
- Revised advance notice bylaws require additional disclosures from nominating stockholders and restrict number of nominees to directors up for election.
- Added compliance requirements for stockholders using universal proxy rules (Rule 14a-19), including certification and evidence submission 5 business days before meeting.
- Updated meeting conduct: presiding officer may set extra attendance procedures; proxy card color must be non-white for soliciting stockholders.
- Added emergency bylaw provision to allow board or committee quorum during situations preventing normal meeting requirements.

## SEC filing metadata
- accession: 0001193125-22-307328
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000119312522307328/0001193125-22-307328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000119312522307328/d410964d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-307328
- JSON: https://secwatch.observer/filing/0001193125-22-307328.json
- Plain text: https://secwatch.observer/filing/0001193125-22-307328.txt

## Key facts
- Governance Changes
  Nurix Therapeutics, Inc.: Amended and restated bylaws to update stockholder meeting procedures, advance notice requirements, universal proxy rules, and other provisions to conform to DGCL amendments and SEC universal proxy rules (effective 2022-12-15).
  - Change: bylaw amendment
  - Effective: 2022-12-15
  source text: On December 15, 2022, in connection with the effectiveness of new Securities and Exchange Commission rules regarding universal proxy cards, certain recent changes to the Delaware General Corporation Law (the “ DGCL ”), and a periodic review of the bylaws of Nurix Therapeutics, Inc. (the “ Company ”), the Company’s board of directors (the “ Board ”) approved and adopted the Company’s amended and restated bylaws (the “ Amended and Restated Bylaws ”), which became immediately effective.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000119312522307328/0001193125-22-307328-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.